Data gathered: May 29
AI Stock Analysis - Tenaya Therapeutics (TNYA)
Analysis generated March 20, 2025. Powered by Chat GPT.
Tenaya Therapeutics is a biotechnology company focused on developing gene therapies and small molecule treatments for heart diseases. Their research is primarily oriented towards discovering innovative solutions for various cardiovascular conditions.
Stock Alerts - Tenaya Therapeutics (TNYA)
 |
Tenaya Therapeutics | May 27 Price is up by 8.2% in the last 24h. |
|
Tenaya Therapeutics | May 21 Price is down by -8.6% in the last 24h. |
|
Tenaya Therapeutics | May 19 Price is up by 7.7% in the last 24h. |
|
Tenaya Therapeutics | May 17 Insider Alert: Higa Tomohiro is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Tenaya Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 89 | Sign up | Sign up | Sign up |
| Webpage traffic | 7,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 5 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 3,890 | Sign up | Sign up | Sign up |
| Instagram Followers | 142 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 13 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,393 | Sign up | Sign up | Sign up |
| Twitter Followers | 468 | Sign up | Sign up | Sign up |
| Twitter Mentions | 57 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 129 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 76 | Sign up | Sign up | Sign up |
| Linkedin Employees | 126 | Sign up | Sign up | Sign up |
About Tenaya Therapeutics
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
| Price | $0.44 |
| Target Price | Sign up |
| Volume | 1,500,000 |
| Market Cap | $74M |
| Year Range | $0.39 - $3.78 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) PT at $6.25May 23 - ETF Daily News |
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)May 15 - Finnhub |
|
|
Barclays PLC Reduces Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA)May 15 - ETF Daily News |
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual MeetingMay 13 - GlobeNewswire |
|
|
Hsbc Holdings PLC Purchases Shares of 31,141 Tenaya Therapeutics, Inc. (NASDAQ:TNYA)May 13 - ETF Daily News |
|
Q2 EPS Forecast for Tenaya Therapeutics Raised by AnalystMay 12 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -27M | 0 | -0.240 |
| Q4 '24 | 0 | 0 | 0 | -24M | -23M | -0.280 |
| Q3 '24 | 0 | 0 | 0 | -26M | -25M | -0.300 |
| Q2 '24 | 0 | 2.1M | -2.1M | -29M | -29M | -0.340 |
| Q1 '24 | 0 | 2.2M | -2.2M | -32M | -32M | -0.400 |
Insider Transactions View All
| Ali Faraz filed to sell 317,325 shares at $0.4. May 16 '25 |
| Tingley Whittemore filed to sell 171,856 shares at $0.4. May 16 '25 |
| Higa Tomohiro filed to sell 98,300 shares at $0.4. May 16 '25 |
| Higa Tomohiro filed to sell 100,535 shares at $0.5. March 10 '25 |
| Higa Tomohiro filed to sell 99,690 shares at $0.5. March 10 '25 |
Similar companies
Read more about Tenaya Therapeutics (TNYA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Tenaya Therapeutics?
The Market Cap of Tenaya Therapeutics is $74M.
What is the current stock price of Tenaya Therapeutics?
Currently, the price of one share of Tenaya Therapeutics stock is $0.44.
How can I analyze the TNYA stock price chart for investment decisions?
The TNYA stock price chart above provides a comprehensive visual representation of Tenaya Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tenaya Therapeutics shares. Our platform offers an up-to-date TNYA stock price chart, along with technical data analysis and alternative data insights.
Does TNYA offer dividends to its shareholders?
As of our latest update, Tenaya Therapeutics (TNYA) does not offer dividends to its shareholders. Investors interested in Tenaya Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Tenaya Therapeutics?
Some of the similar stocks of Tenaya Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.